Header image

Poster Walk - DAA Treatment Therapies

Thursday, August 10, 2017
1:15 PM - 1:45 PM
Exhibition/Grand Ballroom

Speaker

Professor James O'Beirne
Staff Specialist
Sunshine Coast University Hospital

Maximising Access To Hepatitis C (Hcv) Treatment - The Sunshine Coast Experience

1:15 PM - 1:20 PM

Abstract

Biography

Stuart Roberts

SOF/VEL/VOX for 8 or 12 weeks achieves high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3, POLARIS-4 studies

1:23 PM - 1:28 PM

Abstract

Biography

Dr Nick Scott
Econometrician
Burnet Institute

Reaching Hepatitis C Virus Elimination Targets Requires Health System Interventions To Enhance The Care Cascade

1:30 PM - 1:35 PM

Abstract

Biography

A/Prof Simone Strasser
Senior Staff Specialist
Royal Prince Alfred Hospital, Sydney

High SVR Rates With Eight And Twelve Weeks Of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy And Safety Analysis Of Genotype 1-6 Patients Without Cirrhosis

1:38 PM - 1:43 PM

Abstract

Biography


Discussant

David Iser
VMO
Alfred Hospital





loading